Clinical trial / 2017
Soymilk intake increased fecal bifidobacteria and reduced Enterobacteriaceae in healthy adults.
A pilot study evaluated the effect of soymilk intake on the fecal microbiota and metabolic activities in eight healthy adult humans. During the intake period, the number of bifidobacteria in feces was significantly higher on day 14 compared to baseline (p<0.05), while Enterobacteriaceae counts were significantly lower on days 7 and 14 (p<0.05). At the species or group level, all Bifidobacterium groups studied slightly increased, suggesting soymilk intake may contribute to improving the intestinal environment.
- Study type
- Intervention pilot study
- Who was studied
- Eight healthy adult humans
- What was measured
- Fecal microbiota (including Bifidobacterium species and Enterobacteriaceae) and metabolic activities
THE PAPER
The effect of soymilk intake on the fecal microbiota, particularly Bifidobacterium species, and intestinal environment of healthy adults: a pilot study.
Fujisawa T, Ohashi Y, Shin R, Narai-Kanayama A, Nakagaki T. Biosci Microbiota Food Health, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.